Insourcing vs Outsourcing: Choosing the Right Strategy
The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
Aseptic manufacturing is an important part of drug development and commercialization that must be approached with utmost care and attention to detail. Getting a drug product packaged and passing successfully through clinical manufacturing and into the marketplace will depend on many factors, some which are fundamental and straightforward while others require careful consideration of different criteria that can affect each individual situation. The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
Download BioPharm International's
2017 Outsourcing Resources eBook.
Ushering in Industry 4.0 with the IDMO Model to Solve the CGT Manufacturing Bottleneck
May 28th 2025Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be accomplished with smart factories that utilize fully automated manufacturing platforms.
Novel Modalities Spur Shift in Outsourcing Processes and Partnerships
May 8th 2025While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.
